Brief: Somalogic Provides 2021 Financial Guidance Exceeding Initial Merger Combination Projections
23/08/2021 13:50
Aug 23 (Reuters) - CM Life Sciences II Inc CMII.O :
* SOMALOGIC PROVIDES 2021 FINANCIAL GUIDANCE EXCEEDING
INITIAL
MERGER COMBINATION PROJECTIONS
* SOMALOGIC - FY 2021 REVENUE IS EXPECTED TO EXCEED PREVIOUS
PROJECTIONS OF $66.7 MILLION BY 10% OR HIGHER
* SOMALOGIC - FY GROSS MARGINS EXPECTED TO BE MORE THAN 500
BASIS
POINTS AHEAD OF PREVIOUSLY PROVIDED PROJECTIONS OF 51%
Source text for Eikon: ID:nGNX8cwdTj
Further company coverage: CMII.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Somalogic
See all newsBrief: Somalogic Stockholders Vote To Approve Standard Biotools Transaction At Special Meeting
Brief: Madryn Asset Management Demands Somalogic’S Board Address Repeated, Unprecedented Adjournments Of Tainted Special Meeting
Brief: Madryn Asset Management Says It Urges All Somalogic Shareholders To Oppose Transaction With Standard Biotools
Brief: Madryn Asset Management Urges Shareholders To Vote “Against” The Proposed Merger And Allow Somalogic To Pursue Value-Enhancing Alternatives
Brief: Somalogic Board Reiterates Value-Maximizing Transaction With Standard Biotools Is In Best Interests Of All Stockholders